Healthcare Industry Today: Angina Pectoris News http://health.einnews.com/news/angina-pectorisConstantly updated news and information about healthcare industry. CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 http://health.einnews.com/news.php?wid=185304906 27 Aug 2008 20:31 GMT ... tablets), indicated for the treatment of chronic angina in patients who have not achieved an ... symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to ... Cytokinetics plans to start a higher - dose portion of ongoing study for lead drug candidate http://health.einnews.com/news.php?wid=185253108 27 Aug 2008 14:59 GMT ... lead drug candidate for patients with varying heart conditions. The company said it will start ... CK-1827452 for patients with ischemic cardiomyopathy and angina. The conditions refer to patients with congestive ... Cytokinetics to add higher dose of drug in study http://health.einnews.com/news.php?wid=185252438 27 Aug 2008 14:56 GMT ... lead drug candidate for patients with varying heart conditions. The company said it will start ... CK-1827452 for patients with ischemic cardiomyopathy and angina. The conditions refer to patients with congestive ... SmallCapReview.com: Small Cap Stocks to Watch - CHRS, SIFY, CYTK http://health.einnews.com/news.php?wid=185252244 27 Aug 2008 14:55 GMT ... CK-1827452 in patients with ischemic cardiomyopathy and angina. Based on the Safety Review Committee's review ... patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a ... Ark Therapeutics Group Plc Announces Results for the Six Months Ending June 30 2008 http://health.einnews.com/news.php?wid=185238973 27 Aug 2008 13:31 GMT ... delivery platform (as used in Cerepro and Trinam) under development for treatment of refractory angina. This reported very promising results in June 2008. In a heart attack model, treatment with EG011 restored the ejection fraction (the amount of blood pumped ... Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of http://health.einnews.com/news.php?wid=185226134 27 Aug 2008 11:55 GMT ... Cohort in Patients With Ischemic Cardiomyopathy and Angina Cytokinetics, Incorporated (NASDAQ: CYTK) announced the completion ... patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a ... Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452 http://health.einnews.com/news.php?wid=185225197 27 Aug 2008 11:51 GMT ... patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a ... 45 patients each with ischemic cardiomyopathy and angina and an ejection fraction of less than ... --> Cytokinetics Announces Completion of Interim Safety Analysis in Ongoing Phase IIa Clinical Trial of CK-1827452 http://health.einnews.com/news.php?wid=185225017 27 Aug 2008 11:51 GMT ... patients with either acutely decompensated or chronic heart failure. CK-1827452 is the subject of a ... 45 patients each with ischemic cardiomyopathy and angina and an ejection fraction of less than ... Watch How to Check Your Blood Pressure at Home http://health.einnews.com/news.php?wid=185063727 26 Aug 2008 15:31 GMT ... the September 2008 issue of the Harvard Heart Letter . The idea underlies a new ... for choosing a home blood pressure monitor. Chest pain (angina) common after heart attacks Heart disease a ... Manual bids to improve heart patient recovery http://health.einnews.com/news.php?wid=185028901 26 Aug 2008 11:30 GMT ... PEOPLE suffering from heart problems in the Lothians are to be ... will improve the self-care of sufferers of angina, heart failure and other related diseases. Louise ... Patient condemns 'filthy' hospital unit http://health.einnews.com/news.php?wid=185027718 26 Aug 2008 11:28 GMT ... on her lung. She was given a chest X-ray and a heart trace and the problem was found to ... health problems including severe arthritis, asthma and angina, is a member of Scarborough campaign group ... Anthera Pharmaceuticals Advances Global Development Strategy For Varespladib In Patients With Acute Coronary Syndrome http://health.einnews.com/news.php?wid=185025143 26 Aug 2008 10:56 GMT ... death, non-fatal stroke, non-fatal myocardial infarction, unstable angina, and a subset of revascularization following the ... Coronary Syndrome Acute coronary syndrome is a heart condition characterized by chest pain occurring at rest or upon minimal ... DEAR DR. DONOHUE: I am under treatment for angina. I don't have many attacks of chest pain, but when I do, I usually can get rid of them with nitroglycerin. My neighbor, exactly my age, has the same thing: coronary artery disease http://health.einnews.com/news.php?wid=184869988 25 Aug 2008 13:51 GMT ... angina. I don't have many attacks of chest pain, but when I do, I usually ... the same thing: coronary artery disease with angina attacks. His doctor is treating him with ... At a very precise moment in the heart cycle, the cuffs are sequentially inflated, with ... Chelation Therapy Approved As a Treatment for Lead Poisoning http://health.einnews.com/news.php?wid=184856524 25 Aug 2008 12:30 GMT ... but are not restricted to decrease in angina twinge, reduce skin ailments, loss and keeping ... and keeping a standard mass, reduce in heart disorders, developing reminiscence senses and necessity of ... Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome Wi http://health.einnews.com/news.php?wid=184854068 25 Aug 2008 12:26 GMT ... death, non-fatal stroke, non-fatal myocardial infarction, unstable angina, and a subset of revascularization following the ... Pharmaceuticals, Inc. Acute coronary syndrome is a heart condition characterized by chest pain occurring at rest or upon minimal ...